Allied Minds (LSE:ALM), an innovative U.S. science and technology
development and commercialization company, announced today the launch of
Novare Pharmaceuticals, a biotechnology company focused on developing
therapeutic products that help the body replenish and rebuild itself
using its own tissue through the modulation of RHAMM.
for Allied Minds Announces the Launch of Novare Pharmaceuticals, a Biotech Company Focused on Developing Therapeutics that Modulate RHAMM investment picks